New Drug Produced Positive Response In Kidney Cancer

Results of an international trial led by researchers at the University of Texas MD Anderson Cancer Center on MK-6482, showed improved clinical outcomes among renal cancer patients.

from Medindia Health News https://ift.tt/2XdtLSV